{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:05:27Z","timestamp":1694631927741},"reference-count":22,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2621,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2008.01771.x","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T10:16:35Z","timestamp":1210673795000},"page":"889-895","source":"Crossref","is-referenced-by-count":2,"title":["The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal"],"prefix":"10.1155","volume":"62","author":[{"given":"C. R.","family":"Harley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Heien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. P.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults","volume":"285","author":"Adult Treatment Panel III","year":"2001","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB3|cit3","first-page":"54","article-title":"Update for primary healthcare providers: recent statin trials and revised National Cholesterol Education Program III guidelines","volume":"8","author":"Hennekens","year":"2006","journal-title":"Med Gen Med"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejim.2006.03.005","article-title":"Primary prevention in high-risk dyslipidemia patients without an established cardiovascular disease: undertreatment and rationale for lipid-lowering therapy","volume":"17","author":"Zafrir","year":"2006","journal-title":"Eur J Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"133B","DOI":"10.1016\/j.amjcard.2006.11.014","article-title":"Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus","volume":"99","author":"Jones","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.18553\/jmcp.2004.10.3.244","article-title":"Quantifying the effect of applying the NCEP ATP III criteria in a managed care population treated with statin therapy","volume":"10","author":"Quilliam","year":"2004","journal-title":"J Manag Care Pharmacol"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archinte.160.4.459","article-title":"The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals","volume":"160","author":"Pearson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2840-4-7","article-title":"Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study","volume":"4","author":"Berne","year":"2005","journal-title":"Cardiovasc Diabetol"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/174182670100800608","article-title":"Rosuvastatin demonstrates greater reduction of low-density lipoprotein cholesterol compared with pravastatin and simvastatin in hypercholesterolaemic patients: a randomized, double-blind study","volume":"8","author":"Paoletti","year":"2001","journal-title":"J Cardiovasc Risk"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1067\/mhj.2002.128049","article-title":"Effects of rosuvastatin and atorvastatin compared over 52\u2003weeks of treatment in patients with hypercholesterolemia","volume":"144","author":"Olsson","year":"2002","journal-title":"Am Heart J"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1185\/030079903125002405","article-title":"Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial","volume":"19","author":"McKenney","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1592\/phco.26.4.469","article-title":"Effectiveness of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting","volume":"26","author":"Bullano","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1185\/030079907X182167","article-title":"Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals","volume":"23","author":"Kamat","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB16|cit16","unstructured":"Statistical Analysis Software (SAS) 8.2 Release 8.2, Enhancements to SAS\/STAT Software http:\/\/support.sas.com\/rnd\/app\/da\/new\/pdf\/dastat82.pdf"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1592\/phco.2005.25.7.990","article-title":"Rosuvastatin for the treatment of hypercholesterolemia","volume":"25","author":"Culhane","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0749-3797(03)00204-6","article-title":"Patients\u2019 achievement of cholesterol targets: a cross-sectional evaluation","volume":"25","author":"Olson","year":"2003","journal-title":"Am J Prev Med"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1185\/030079907X219580","article-title":"Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States","volume":"23","author":"Fox","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"Suppl. 15","key":"10.1111\/j.1742-1241.2008.01771.x-BIB20|cit20","first-page":"S412","article-title":"Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice","volume":"12","author":"Ohsfeldt","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9343(02)01303-7","article-title":"Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice","volume":"113","author":"Frolkis","year":"2002","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2008.01771.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2146\/060104","article-title":"Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting","volume":"64","author":"Bullano","year":"2007","journal-title":"Am J Health Syst Pharm"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2008.01771.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2008.01771.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:07:47Z","timestamp":1643350067000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2008.01771.x"}},"subtitle":["Effectiveness of rosuvastatin vs. other statins"],"short-title":[],"issued":{"date-parts":[[2008,6,28]]},"references-count":22,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2008.01771.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,28]]}}}